Genix Announces TSX-V Approval of Warrant AmendmentsFebruary 8, 2024Vancouver, British Columbia–(Newsfile Corp. – February 6, 2024)Genix Pharmaceuticals Corporation (TSXV:…
Genix Announces Warrant Repricing and Seeks ExtensionFebruary 8, 2024Vancouver, British Columbia–(Newsfile Corp. – January 18, 2024) – Genix…
Genix Announces AGM ResultsMay 26, 2023Vancouver, British Columbia, May 26, 2023 – Genix Pharmaceuticals Corporation (TSX-V: GENX; OTCQB: GENPF)…
Genix Announces Change of AuditorNovember 14, 2022Vancouver, British Columbia, November 10, 2022 – Genix Pharmaceuticals Corporation…
Genix Announces Auditor ResignationNovember 14, 2022Vancouver, British Columbia, September 6, 2022 – Genix Pharmaceuticals Corporation…
Genix Receives Approval to Extend Warrants from the TSX Venture ExchangeJuly 28, 2022Vancouver, British Columbia, July 28, 2022 – Genix Pharmaceuticals Corporation (TSX-V: GENX; OTCQB: GENPF)…